Meksa Yatırım
Meksa Yatırım is a venture capital firm based in Beykoz, Turkey. This profile covers what we know about Meksa Yatırım and how founders can get in front of it in 2026.
Meksa Yatırım is an investment management company that provides tech based solutions in the capital market.
- Location
- Beykoz, Turkey
- Founded
- 1990
- Team size
- 10001+
How to pitch Meksa Yatırım
The founders who hear back from Meksa Yatırım lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Meksa Yatırım
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Meksa Yatırım." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/meksa-yat-r-m
Frequently Asked Questions
What is Meksa Yatırım?
Meksa Yatırım is a venture capital firm based in Beykoz, Turkey. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is Meksa Yatırım based?
Meksa Yatırım is based in Beykoz, Turkey. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Meksa Yatırım?
Unlock a verified email for Meksa Yatırım and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.